China CureThe Rise of a Biotech, AI Medicine and Global Health Superpower

Pre-order
Format

£25.00

Pre-order

Published 31 October 2026

About this book

A unique insider perspective on the biggest health care revolution in the world

  • Combines the author’s personal experience with her professional insight in working in health care and biotech in the UK and China
  • Examines the Chinese innovations that are rapidly outstripping those from Europe and the US - feeding fears and conspiracy theories of China taking over drug supplies and weaponizing them against the West
  • Includes interview material and first-hand experience of frontline medicine in China

This is a book about health under pressure, and about what becomes possible when a country of immense scale is forced to innovate in one of the most difficult and intimate domains of public life. Some of what emerges is impressive, some of it is troubling and much of it remains unresolved. China has embraced innovation and technology in health care to tackle its own huge healthcare burdens. The strain of chronic ill health is both a challenge to the existing system and an opportunity to innovate in biotechnology and digital health. China’s ability to operate at tremendous scale and pace has enabled it to become a global health leader in a matter of decades. Dr Ruby Wang offers an insider’s perspective of where it offers lessons for both developed and developing countries, and how its rise is already impacting the practice and delivery of medicine worldwide.

Reviews

Ruby Wang offers a timely and incisive guide to China's rising medical power and its international reach. This is a much-needed book.
In a world of AI, changing demographics and increasing healthcare costs, how can societies adapt? Few Westerners think to look at the immense changes in healthcare happening in China, but Ruby Wang’s fascinating book brings together news from the Chinese tech, policy and clinical frontlines with an understanding of the human heart that makes this a must-read for all those who want to address one of the world’s most challenging issues.
China's emergence as a global leader in biotech, medical innovation and AI-enabled care is one of the most consequential transformations shaping our world today. Its effects reach far beyond healthcare, reshaping economic competitiveness, technological leadership and geopolitical power. This book cuts through the hype and the fear; it is essential reading for anyone seeking to understand these remarkable changes.
A great shift of industrial competitiveness from the West to the East is redefining our century. Ruby Wang charts this historic transformation with the expert eye of an insider and the pen of a superb storyteller, capturing both the economic significance and human consequences behind China's dramatic rise as a global health power.
Health has now become a matter of diplomacy, economic security and modern statecraft for every country around the world. Drawing on rare personal and professional experience, Ruby Wang provides an authoritative account of why China's global role in health has become one of the defining geopolitical issues of our time.
At a time when countries at every level of development are rethinking health security and technological innovation, Ruby Wang's timely and urgent book shows why China’s health rise has become essential in our future of global cooperation and competition.
China is now a force to be reckoned with, especially in biotechnology and AI. Ruby Wang is an exceptional guide to this transformation, uniquely combining clinical insight, policy experience and a deeply personal understanding to make this book compelling and authoritative.
Table of contents

Foreword by Kerry Brown
Preface
Acknowledgements
Abbreviations


Introduction. The Global Stakes

1. Crisis and Culture
2. Biotech Powerhouse
3. Digital Health Revolution
4. The Human Side
5. Institutions of Power
6. Across Borders

Conclusion. Looking Ahead

Notes
Index

About the author

Ruby Wang

Dr Ruby Wang is a clinician, strategist and writer working across health, technology, policy and global governance. Born in China and raised in the UK, she brings together clinical, policy and personal experience of health systems across borders.

She trained in medicine at Cambridge, Oxford and University College London, including a master’s in neuroscience and psychology, and later completed another master’s in global affairs at Tsinghua University as a Schwarzman Scholar. She has worked on healthtech and policy alongside clinical practice in the UK’s National Health Service, and during the COVID-19 pandemic, she served as Head of Health for the UK Government in China and as Health Advisor to the United Nations in Beijing. She is founder of LINTRIS Health consultancy, serves on the Digital Health Council at the Royal Society of Medicine, is a Fellow on Global Health at the Asia Society and editor at ChinaHealthPulse, a newsletter and podcast that diagnoses the global impact of China’s health.